from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3736/-

LFCtreatmentdescriptionclass of inhibitor

1.469

Amikacinug/mL Amikacintranslation

1.419

Cap5-10ug/mL Capreomycintranslation

2.317

Rox10-50 ug/mL Roxithromycintranslation

0.713

SM2-5 ug/mL Streptomycintranslation

2.647

Tet5-10 ug/mL Tetracyclinetranslation

-0.105

Rif0.2-5ug/mL Rifampicintranscription

-0.663

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.615

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.601

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.327

CPZ10-50 ug/mL Chlorpromazinerespiration

0.156

Clofazimine10-13 ug/mL Clofaziminerespiration

0.049

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.206

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.444

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.179

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.029

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.363

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.754

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.886

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.083

KCN5-20 ug/mL Potassium cyaniderespiration

-0.040

NaN30.2-2 mM Sodium aziderespiration

0.430

Nigericin50 uM Nigericinrespiration

-0.504

TRC10-150 ug/mL Triclosanrespiration

0.990

TRZ10-25 ug/mL Thioridazinerespiration

0.513

Valinomycin0.5-10 uM Valinomycinrespiration

-0.867

ZnSO42 mM ZnSO4respiration

-0.287

menadione6-10 ug/mL Menadionerespiration

-0.052

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.073

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.071

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.051

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.238

NRP_1Non-replicating persistence stage 1dosRassociated

0.355

Amp0.2mg/mL AmpicillincellWall

-0.259

Cephalexin20-100 ug/mL CephalexincellWall

0.084

Cerulenin0.32-5 ug/mL CerulenincellWall

0.271

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.254

EMB10-20 ug/mL EthambutolcellWall

-0.252

Eta12-40 ug/mL EthionamidecellWall

0.625

INH0.2-0.4 ug/mL IsoniazidcellWall

0.231

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.359

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.277

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.705

BZA0.12 mg/mL BenzamidearomaticAmides

-0.431

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.418

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.200

H2O24 mM hydrogen peroxideDNAdamaging

-0.220

Levo10 ug/mL LevofloxacinDNAdamaging

-0.022

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.872

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.124

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.176

UVUV-irradiationDNAdamaging

0.738

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.220

Antimycin12.5-50 ug/mL Antimycin A?

0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.399

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.258

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.695

PA8240.2-2 ug/mL PA-824?

-1.293

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.759

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.016

Verapamil50 uM Verapamil?

-0.027

mercaptoethanol2 mM 2-Mercaptoethanol?

0.168

methoxatin10-20 ug/mL Methoxatin?